Granules India (NS: ) Ltd., a pharmaceutical manufacturing company, has reported a significant increase in its second-quarter revenue for the fiscal year 2024. The Hyderabad-based company also saw an impressive 11% year-over-year growth in its North American market, with revenues reaching Rs. In addition to its current financial achievements, Granules India is embarking on an ambitious capital expenditure plan. InvestingPro InsightsIn line with the detailed financial report of Granules India Ltd , InvestingPro provides some insightful tips and real-time data. Despite a recent slowdown, revenue growth has been consistent, and the stock is currently trading near its 52-week high.

Source: The North Africa Journal November 13, 2023 13:28 UTC